| ||||
Orbital says report on October rocket explosion nearly done Read More » SpaceX rocket blasts off, then lands - too hard - on ocean barge Read More » SpaceX Narrowly Misses Rocket Landing After Dragon Spaceship Launch Success Read More » Heart chip beats toward better drug screening, personalized medicine By Ben Gruber BERKELEY, CALIFORNIA - Bioengineers in California have developed a system that allows human heart cells to function outside the body, a development that could potentially prove a powerful tool for drug development as well as pave the way toward personalizing treatments for patients with heart conditions. "It is the first demonstration of an actual human heart which is based in a system that is mimicking the physiology as close as possible," said Anurag Mathur, a principle scientist involved in the research. The device has been named a "heart-on-a-chip" and it is comprised of cell layers derived from IPS stem cells that form heart tissue which is housed on a small slab of silicon. The fluid that we are interested in comes across this tissue and then it bathes it with the drug," said Kevin Healy, a professor of bioengineering and material science at the University of California Berkeley. "We give it caffeine, heart-on-a-chip beats and accelerates its heart rate. Read More »Gray Whale Breaks Mammal Migration Record Read More » Holy Flying Fish! Why Jumping Asian Carp Bombard Rowers Read More » Boneworms Dined on Ancient Sea Serpents Read More » IRS in Space: How Will We Tax a Mars Mission? Read More » Comet Comes to Life in Amazing Rosetta Spacecraft Photo Montage Read More » AstraZeneca science is on the move, one year on from Pfizer bid By Ben Hirschler LONDON (Reuters) - Having seen off a hostile $118 billion bid launched a year ago by U.S. rival Pfizer, Anglo-Swedish company AstraZeneca is on the move -- quite literally. Chief Executive Pascal Soriot is making AstraZeneca more nimble as hopes build for its cancer pipeline, but he still has his work cut out to keep 2015 earnings above the floor needed to protect his bonus. Investors must balance the short-term challenges posed by a massive "cliff" of patent expiries for older drugs against AstraZeneca's long-term promise that sales can reach $45 billion in 2023 from $26 billion last year. So far, Frenchman Soriot has played his hand well, given the inevitable disappointment among some shareholders at the rejection of Pfizer's final 55 pound-a-share offer last year. Read More »Why Humans Have Chins Read More » 1st Color Image of Pluto Snapped by Approaching NASA Probe (Photo) Read More » Early Earth May Have Absorbed Mercury-like Object Read More » Gestational Diabetes May Be Tied to Autism in Children Women who develop gestational diabetes early in their pregnancy have a higher chance of having a child with autism than women who don't develop the condition, a new study suggests. Researchers found that mothers-to-be who developed gestational diabetes — high blood sugar during pregnancy in women who have never had diabetes — by their 26th week of pregnancy were 63 percent more likely to have a child diagnosed with an autism spectrum disorder (ASD) compared with women who did not have gestational diabetes at any point during their pregnancy (and who also did not have type 2 diabetes prior to pregnancy). The finding does not mean that autism is common among children born to women who had gestational diabetes. Read More »Are Health Apps Harmful or Helpful? Experts Debate Health apps are ubiquitous, but do they do more harm than good? Health apps have a range of goals — some simply encourage people to adopt healthy behaviors, while others actually help people manage conditions such as diabetes or high blood pressure. These researchers cited numerous examples of manufacturers recalling their own apps for gross failure, such as miscalculating insulin doses for people with diabetes. Read More »Is Marijuana Good Medicine or Dangerous? Poll Reveals What the US Thinks Read More » Pop! Knuckle-Cracking Noise Finally Explained Read More » U.S. study calls into question tests that sequence tumor genes By Julie Steenhuysen CHICAGO (Reuters) - New cancer tests that sequence only a patient's tumor and not normal tissue could result in a significant number of false positive results, potentially leading doctors to prescribe treatments that might not work, U.S. researchers said on Wednesday. The tests take advantage of new treatments that target changes in the DNA of tumor cells that are important for their survival. The issue is that few of these tests look at DNA from healthy cells to compare which mutations patients were born with and which are unique to the cancer, said Dr. Victor Velculescu of Johns Hopkins and a principal in Personal Genome Diagnostics, a company co-founded by the researchers. Read More »NASA probe nearing close encounter with unexplored Pluto Read More » Orbital, GenCorp spar over cause of October rocket crash Read More » Snap, crackle, pop: study reveals secret behind knuckle-cracking Read More » | ||||
| ||||
|
Wednesday, April 15, 2015
FeedaMail: Science News Headlines - Yahoo! News
Tuesday, April 14, 2015
FeedaMail: Science News Headlines - Yahoo! News
| ||||
Bad Weather Delays SpaceX Rocket Landing Attempt, Dragon Launch Read More » U.S. satellite launcher gets first Vulcan rocket request - change the name By Irene Klotz CAPE CANAVERAL, Fla. (Reuters) - Hours after unveiling its next-generation "Vulcan" rocket, the company that launches most of America's satellites, United Launch Alliance (ULA), ran into its first problem - the rocket's name. "Vulcan is a trademark of Vulcan Inc. and we have informed ULA of our trademark rights," Chuck Beames, president of the Paul Allen-backed Vulcan Aerospace, told Reuters. "Paul Allen and Vulcan were early leaders within space exploration with the launch of SpaceShipOne more than a decade ago. We are flattered by ULA's tribute to our legacy by naming their new rocket 'Vulcan'," Beames said. Read More »NASA Scientists Cook Up Building Blocks of Life in Lab Read More » Battered Remains of Medieval Knight Discovered in UK Cathedral Read More » How to Avoid a Shark Attack Read More » Robot chef serves up the future of home cooking The system was created by UK-based Moley Robotics, which aims to develop a consumer version with an affordable price tag within two years, supported by an iTunes-style library of recipes that can downloaded for the robo-chef to cook in the home. It features two fully articulated hands, made by the Shadow Robot Company, whose products are used in the nuclear industry and by NASA. The dextrous hands are able to faithfully reproduce the movements of a human hand, cooking up Michelin-starred delicacies with all the skill and flair of a master chef. Key to the robot's kitchen prowess is the way its movements have been 3D-mapped to those of professional chef Tim Anderson. Read More »Woman's 'Burning Mouth Syndrome' Had Strange Cause The woman had a case of a condition called "burning mouth syndrome," which is a chronic, burning sensation inside the mouth, usually in the lips, tongue or palate, according to the study, published April 1 in the journal BMJ Case Reports. "It's common in postmenopausal women, and affects up to 7 percent of the general population," said study co-author Dr. Maria Nagel, a neurovirologist and professor at the University of Colorado School of Medicine in Aurora. Nagel compared the feeling to a "sunburn inside the mouth," adding that it feels similar to the pain caused by a tooth infection or a root canal. The virus commonly causes cold sores around the mouth and lips, but the woman didn't have any cold sores. Read More »Man Tears Tendon After Playing 'Candy Crush' for Weeks A California man tore a tendon in his thumb after playing a puzzle game on his smartphone too much, according to a new report of the case. The case shows that, in a sense, video games may numb people's pain and contribute to video game addiction, they said. "We need to be aware that certain video games can act like digital painkillers," said Dr. Andrew Doan, a co-author of the case report and head of addictions research at the Naval Medical Center San Diego. Read More »Marijuana Extract May Help Reduce Epilepsy Seizures A medicine made from marijuana may provide some relief to people with severe epilepsy who don't get better after trying other treatments, according to a new study. In the study, researchers examined 137 people, ranging in age from toddlers to adults, who all had severe epilepsy, a condition that causes seizures. The researchers noted that the participants knew they were receiving the extract, and that the study did not include a comparison group of people with severe epilepsy who were not given the marijuana drug or who were given a placebo instead. "While the findings are promising, more research is needed, such as randomized-controlled trials to help eliminate the possibility of a placebo effect," said study author Dr. Orrin Devinsky, director of New York University Langone Comprehensive Epilepsy Center. Read More »Screwing Up Artificial Intelligence Could Be Disastrous, Experts Say Read More » Ebola Vaccine Starts Testing in Sierra Leone A new Ebola vaccine study starting in Sierra Leone will test the vaccine in thousands of people who are working to fight the epidemic, health officials said today. For the study, called STRIVE, researchers will enroll about 6,000 people — all of them health care workers or others who are on the front lines, such as cleaning staff at clinics and burial workers, according to the Centers for Disease Control and Prevention. Participants will receive the Ebola vaccine either right away or six months later (as part of a control group). "I'm hopeful that what we learn from this clinical trial will help us get closer to finding a safe and effective tool" to protect people against Ebola during the current outbreak and future ones, Dr. Anne Schuchat, director of CDC's National Center for Immunization and Respiratory Diseases, said at a news conference today (April 14). Read More »Rocket startup unveils battery-powered engine for small satellite launches By Andrea Shalal COLORADO SPRINGS, Colo. (Reuters) - Rocket Lab, a privately-held company financed by weapons maker Lockheed Martin Corp and other high-tech investors, on Tuesday said its low-cost Electron launch system for small satellites will be the first rocket powered by batteries. Chief Executive Peter Beck said the company founded in 2008 to help commercialize the space business, expected to carry out the first flight of its all-composite Electron launch vehicle and the new Rutherford engine before the end of the year. Rocket Lab, which is based in Los Angeles and has a launch site in New Zealand, says the two-stage Electron rocket will make it cheaper and quicker to launch small 100-kilogram payloads into low-earth orbit. The company expects to start launching satellites for customers in 2016, and eventually aims to launch a satellite a week. Read More »Dark Matter Illuminated in New High-Resolution Maps Read More » Giant Atom Smasher Revs up: Physicists Reveal What They're Looking For Read More » It's a Girl! Healthy Giraffe Born at Dallas Zoo Read More » | ||||
| ||||
|